top of page

Accessing Antiviral Treatment for FIP

Access to the various anti-viral compounds that are used to treat FIP varies by country.  While in some cases it must be sourced by owners rather than the veterinarian, more and more countries now have access to legal or regulated FIP treatment available by veterinarian prescription.  This list attempts to gather info on access via veterinary channels, as well as the most reliable resources to help veterinarians and owners access treatment.  This page also provides cost estimates, although costs vary by location, supplier and over time.

Ducky.jpg

From time to time there may also be studies or trials available which may provide access to treatment.

GS-441524

United States

Compounded GS-441524 is available from multiple pharmacies in the US.  Different formulations are available, including tablets, capsules, and liquid oral suspension. 

  • Stokes Pharmacy offers the BOVA formulations of tablets and liquid oral suspension which has been in use in the UK and Australia, and has been validated in several studies.  Stokes Pharmacy is licensed and is able to ship to all 50 states.  Additional resources are available here: https://www.stokespharmacy.com/fip/veterinary-resources/

    • Expedited/overnight shipping available.  Same day pickup can be arranged from their New Jersey location​

  • Mixlab offers tablets and liquid oral suspension in all 50 states

    • Mixlab offers a discount program for rescues​.  Contact them for details.

    • Expedited/overnight shipping available.  Same day pickup can be arranged from their location in Los Angeles

  • Specialty Vet Pharmacy is licensed in 41 states, and has compounded GS available as liquid oral suspensioncapsules and chewables.

    • Expedited/overnight shipping available. Same day pickup can be arranged from their pharmacy in Texas​

​

Note: For a more complete list of pharmacies offering FIP treatment in the US, please see the US Pharmacies Offering Compounded FIP Treatment  pdf.

​

Compounded GS-441524 can be held as office stock in all 50 states, except: Arkansas, Massachusetts, New Mexico, New York, Oregon, Rhode Island and West Virginia 

Canada

In Canada, GS-441524 is available as a tablet and liquid oral suspension from specials compounder BOVA via Canada’s Emergency Drug Release (EDR) program.  More information about accessing treatment under the EDR program:

United Kingdom
Australia
Sweden
Czech Republic
Finland
Ireland
Cyprus
Hong Kong
Singapore

GS-441524 is available as a tablet or liquid oral suspension as an extemporaneous preparation from specials compounder BOVA.​

Globally (other countries not listed)

In many countries GS-441524 is unavailable through veterinary channels, however the situation is rapidly changing.  For up-to-date information on availability, cat owners can join the FIP Global CATS FB group which can provide information on FIP treatment options in their country.

Molnupiravir and EIDD-1931

United States

Molnupiravir is available in the US for veterinary prescription from Wedgewood Pharmacy as a liquid oral suspension or as capsules.​

  • Expedited shipping is available.  Same day pickup can be arranged from their facility in New Jersey

​​

Note: For a more complete list of pharmacies offering FIP treatment in the US, please see the US Pharmacies Offering Compounded FIP Treatment  pdf.

​

Compounded Molnupiravir can be held as office stock in all 50 states, except: Arkansas, Massachusetts, New Mexico, New York, Oregon, Rhode Island and West Virginia 

Canada

In Canada, EIDD-1931, the active ingredient in Molnupiravir is available as an extemporaneous preparation from specials compounder BOVA 

via Canada’s Emergency Drug Release (EDR) program.  More information about accessing treatment under the EDR program:

Australia
 

In Australia, Molnupiravir can be legally prescribed by veterinarians.  To save on cost, owners can legally import Molnupiravir via the Personal Importation Scheme.  Use of Molnupiravir and importation under the Personal Importation Scheme is covered in Richard Malik's article "A key role for molnupiravir in the management of cats with FIP in Australia." (The Veterinarian, October 2022)

​

Additionally, EIDD-1931, the active ingredient in Molnupiravir is available as an extemporaneous preparation from specials compounder BOVA 

New Zealand
 

In New Zealand, Molnupiravir can be legally prescribed by veterinarians.  To save on cost, owners can legally import Molnupiravir, and it is available in compounding pharmacies.  

​​

United Kingdom
Sweden
Czech Republic
Finland
Ireland
Cyprus
Hong Kong
Singapore

EIDD-1931, the active ingredient in Molnupiravir is available as an extemporaneous preparation from specials compounder BOVA 

Globally

Molnupiravir is available in many countries, often in many generic human formulations.  Although there are no specific veterinary channels, in some countries, such as Russia, Bangladesh, India, Iraq, etc it appears that it can be accessed fairly easily by veterinarians, while in other countries access remains restricted.  For up-to-date information on availability, cat owners can join the FIP Global CATS FB group which can provide information on FIP treatment options in their country.

Remdesivir

United States

Remdesivir is FDA approved for use in humans for COVID19, making it legal to prescribe off-label.  Unfortunately, however, there are currently no vet distributors currently carrying it and it is not generally available through outpatient pharmacies.​  The best option currently to obtain this is from a human hospital pharmacy (which treats COVID in-patient).

​

Remdesivir can be stocked in-clinic.

Canada

In Canada, Remdesivir is available as an extemporaneous preparation from specials compounder BOVA 

via Canada’s Emergency Drug Release (EDR) program.  More information about accessing GS under the EDR program:

United Kingdom & Australia

In the United Kingdom and Australia, Remdesivir is available as an extemporaneous preparation from specials compounder BOVA.

Globally

Remdesivir has been approved for human use in over 50 countries, including Australia, India, United Arab Emirates, Argentina, Japan, Canada, Lebanon, Russia, Great Britain, European Union (about 30 countries), United States of America, Brazil, Israel, Guatemala, Qatar, Iraq, Saudi Arabia, South Korea, Kuwait, Hong Kong, Turkey, Switzerland, Singapore, Bahrain, Mexico, Jordan, and Taiwan.  Although there are no specific veterinary channels, in some countries, such as Bangladesh, India, Iraq, etc it appears that it can be accessed fairly easily by veterinarians, while in other countries access remains restricted.  For up-to-date information on availability, cat owners can join the FIP Global CATS FB group which can provide information on FIP treatment options in their country.

Paxlovid (nirmatrelvir/ritonavir)

United States

Paxlovid is FDA approved for use in humans for COVID19, making it legal to prescribe off-label.  Unfortunately, however, there are currently no vet distributors currently carrying it but it is widely available through outpatient pharmacies.​  Veterinary prescriptions can be written and filled at most common outpatient pharmacies, such as Walgreens,CVS, etc.

​

Paxlovid can be held as office stock.

Globally

Paxlovid (or generic forms of it)  has been approved for human use in many countries.  Although there are no specific veterinary channels, in some countries, it can be legally prescribed and  accessed fairly easily by veterinarians, while in other countries access remains restricted.  For up-to-date information on availability, cat owners can join the FIP Global CATS FB group which can provide information on FIP treatment options in their country.

GC376

GC376 is being developed to be brought to market for treatment of FIP by Anivive Lifesciences. They have submitted a Reasonable Expectation of Effectiveness section to the FDA-CVM. 

​​

bottom of page